Multifunctional Nutrition Tube in Dysphagia for Nasopharyngeal Carcinoma
NCT06328868 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2024-03-25
Summary
Baseline information (demographics, medical history, etc.), nutritional status at admission and after treatment, depression, dysphagia, and quality of life (QOL) after treatment as well as adverse events are compared.
Palliation to delayed dysphagia after radiotherapy for nasopharyngeal carcinoma (NPC) continues to be a challenge. Although nasogastric tube feeding (NGT) has been adopted widely, the weaknesses have yet to be improved by another enteral nutrition support mode. This study aims to observe the clinical efficacy of intermittent oro-esophageal tube feeding (IOE) in the treatment of delayed dysphagia after radiotherapy for (NPC). This is a prospective multicenter study with patients with delayed dysphagia after radiotherapy for NPC. Patients enrolled are randomly divided equally into the observation group and the control group. All patients receive conventional care, and the observation group received IOE while the control group received NGT for enteral nutrition support.
Conditions
Interventions
- DEVICE
-
Intermittent Oral-esophageal Tube Feeding
The specific procedure was as follows: the infant was placed in a semi-recumbent or sitting position with the head fixed. Before each feeding, the infant's oral and nasal secretions were to be cleared. An intermittent oro-esophageal tube was appropriately lubricated with water on the head part. The professional medical staff held the tube and slowly inserted it through one side of the mouth into the upper part of the esophagus. The depth of insertion depended on the patient's age and height. After each feeding, the tube was immediately removed, and the patient was held upright for at least 30 minutes in case of reflux.
- DEVICE
-
Nasogastric Tube Feeding
Nasogastric Tube Feeding were used for feeding to provide nutritional support. Each feeding was administered by a nurse using the infant's mother's breast milk through the tube. The amount of each feeding varied from 20 to 100 ml depending on the age of the infant, with feedings given every 2 to 3 hours, approximately 10 times per day. The duration of each feeding procedure ranged from 10 to 20 minutes. The total daily intake ranged from 200 to 1000 ml. Each tube was kept indwelling for 5 to 7 days. When the tube needed to be replaced, it was removed after the last feeding of a day and a new tube was to be inserted through the other nostril on the following morning to continue the nutritional support.
- BEHAVIORAL
-
comprehensive rehabilitation therapy
Both groups were given comprehensive rehabilitation therapy. The main intervention measures included: 1) non-invasive ventilator treatment, generally at least once every night and typically not exceeding continuous daily usage.; 2) attention to feeding and sleeping positions, with a recommended sleeping position of lateral recumbent and the head of the bed raised by 20-30°; 3) swallowing function training, such as tongue muscle stretching training, assisted anterior jaw protrusion training, lemon ice stimulation to the soft palate, pharyngeal wall, etc., generally 5 days per week, twice per day, 5-20 minutes each time; 4) pulmonary ultrashort wave therapy, generally at least 2-3 times a week, and not more than once a day; 5) physical therapy, such as intensive training for gross motor functions including lifting the head, turning over, sitting, crawling, standing, etc., generally 3-5 days per week, 1-2 times per day, 5-20 min each time.
Sponsors & Collaborators
-
Copka Sonpashan
lead OTHER_GOV
Principal Investigators
-
Nieto Luis · Site Coordinator of United Medical Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-31
- Primary Completion
- 2024-12-31
- Completion
- 2024-12-31
More Related Trials
-
Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia
NCT00665197 ·Status: COMPLETED ·Phase: PHASE3
-
Focal Cryoballoon Ablation for Malignant Dysphagia
NCT06618742 ·Status: RECRUITING ·Phase: NA
-
Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
NCT00193882 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Study of Brachytherapy and Endoscopic Stenting for Dysphagia in Esophago-Gastric Junction Cancer
NCT01786278 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer
NCT02027948 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Improve Therapeutic Outcomes for Dysphagia After Radiation Therapy
NCT02564887 ·Status: TERMINATED ·Phase: NA
-
To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy
NCT04199832 ·Status: COMPLETED
-
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
NCT05833594 ·Status: RECRUITING
-
Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy
NCT04019548 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Study on the Treatment of Anorexia and Cachexia in Advanced Gastric and Esophageal Cancer With Nanosized Megestrol Acetate Combined With Immunochemotherapy
NCT06963593 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy
NCT01164566 ·Status: TERMINATED ·Phase: NA
-
Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT00094861 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Support During Induction Therapy for Esophageal Cancer
NCT05314946 ·Status: RECRUITING ·Phase: NA
-
Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT03286920 ·Status: UNKNOWN
-
Chemotherapy in the Context of Esophageal and Gastroesophageal Junction Cancer Cachexia
NCT05954117 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Association of Nutritional Status With Immune Checkpoint Inhibitor Efficacy in Metastatic Metastatic Esophagogastric Cancer.
NCT06923020 ·Status: ENROLLING_BY_INVITATION
-
Dysphagia Assessment After Swallowing Sparing RadioTherapy
NCT03448341 ·Status: COMPLETED
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With Chemotherapy
NCT06022770 ·Status: UNKNOWN ·Phase: NA
-
Personalized Nutrition Counseling and Nutritional Status of Esophageal Cancer and HNSCC Patients Undergoing CCRT
NCT06829095 ·Status: RECRUITING
-
Quality of Life Assessment of Cryotherapy in Esophageal or Gastroesophageal Cancer
NCT03285035 ·Status: UNKNOWN
-
Chemoradiotherapy for Advanced Esophageal Cancer
NCT02297217 ·Status: RECRUITING ·Phase: PHASE2
-
Lymphoscintigraphy to Detect Early Metastases in Patients With Cancer of the Mouth or Throat
NCT00012168 ·Status: COMPLETED ·Phase: NA
-
ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study
NCT01915693 ·Status: COMPLETED ·Phase: PHASE3
-
IMRT and Primary Transoral Surgery in the Treatment of Squamous Cell Carcinomas
NCT04224389 ·Status: RECRUITING